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ABSTRACT
Objective: To identify representations regarding adherence to the treatment of 
multidrug-resistant tuberculosis from the perspective of patients who were discharged 
upon being cured. Method: A qualitative study with patients who completed the drug 
treatment for multidrug-resistant tuberculosis in São Paulo. Social Determination was 
used to interpret the health-disease process, and the testimonies were analyzed according 
to dialectical hermeneutics and the discourse analysis technique. Results: Twenty-one 
patients were interviewed. The majority (80.9%) were men, in the productive age group 
(90.4%) and on sick leave or unemployed (57.2%) during the treatment. Based on the 
testimonies, three categories associated with adherence to treatment emerged: the desire 
to live, support for the development of treatment and care provided by the health services. 
Conclusion: For the study sample, adherence to the treatment of multidrug-resistant 
tuberculosis was related to having a life project and support from the family and health 
professionals. Free treatment is fundamental for adherence, given the fragilities arising 
from the social insertion of people affected by the disease. Therefore, special attention is 
required from the health services to understand patient needs. 
DESCRIPTORS
Tuberculosis; Tuberculosis, Multidrug-Resistant; Medication Adherence; Health 
Services Accessibility; Public Health Nursing.
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INTRODUCTION
With the advent of chemotherapy and advances in diag-
nostics, it was believed that tuberculosis (TB) would be easily 
controlled. However, it continues to present relevance as a 
public health problem despite the possibility of being cured 
through appropriate treatment(1).
It is estimated that in 2016 there were 10.4 million new 
cases of TB and 490 thousand new cases of Multidrug-
Resistant TB (MDR-TB). In Brazil, there were a thousand 
new cases of TB and a thousand cases of MDR-TB(2). In 
addition to the alarming number of MDR-TB cases world-
wide, the World Health Organization (WHO) estimates 
that only 20% (125,000) of these cases were reported in 
2015, and that the treatment success rate was 52% in 2013. 
This data is even more surprising for extremely resistant 
TB, only reaching a success rate in 28% of patients(3). Of 
the countries with high MDR-TB occurrence, six countries 
including Brazil present subnational data on monitoring 
resistant cases. Just in 2014, Brazil launched a comprehensive 
national surveillance system to monitor drug resistance(3).
TB is defined as MDR-TB when resistance to at least 
rifampicin and isoniazid is observed, which together with 
pyrazinamide and ethambutol constitute the basic regimen 
for treatment of TB. Isoniazid and rifampicin are the drugs 
that most present bactericidal activity, and the latter has 
greater sterilizing power. MDR-TB demands a much longer 
treatment period, corresponding to six months in the basic 
regimen being extended to 18 to 24 months, as long as the 
clinical and radiological evolution are considered, and the 
bacteriological examination is negative. The complexity of 
MDR-TB treatment is even greater when considering that 
the medication is injectable in the first six months, and it 
can produce very relevant side effects such as nephrotoxic-
ity, hearing loss, peripheral neuropathy, optic neuritis, ana-
phylaxis, seizures, psychotic symptoms, nausea, vomiting, 
arthralgia, headache, tinnitus and insomnia(4).
Several studies affirm that attention and constant vigi-
lance for MDR-TB by the health authorities is necessary 
since it represents a further challenge for controlling TB(5-6). 
However, there is a lack of studies on the aspects related to 
adherence to MDR-TB treatment. Among the studies found, 
most of them do not explore the association between adher-
ence and the aspects closely related to the causality network, 
such as the living and working conditions of the patients(7-9).
Based on the assumption that adherence to MDR-TB 
treatment is associated with these conditions, in addition 
to access to health services and the way the TB Control 
Program is operationalized, this study aimed to identify 
representations about the adherence of people who suc-
cessfully completed treatment for MDR-TB in a tertiary 
referral center in the state of São Paulo.
METHOD
A descriptive study with a qualitative approach was car-
ried out. The individual testimonies constituted the raw mate-
rial for apprehension and analysis of the conceptions regard-
ing the health-disease process, the living reality of the patient 
being treated, the health care and adherence to treatment. 
The study was conducted at a Tertiary Reference Center 
for TB and MDR-TB control, located in the central region 
of the city of São Paulo, administered by the state govern-
ment. We interviewed people who experienced treatment for 
pulmonary MDR-TB and who were in follow-up after being 
cured, from April to September 2012. We chose to interview 
patients who were discharged from 2008 to 2012, consider-
ing the most recent discharge period to ensure greater prob-
ability of attending the consultations, considering that these 
patients still had follow-up consultations. Exclusion criteria 
were: being less than 18 years old and having a mental dis-
order that made it impossible to participate in the study.
A questionnaire containing open questions was used in 
order to enable the subjects to report their experiences of 
the disease, their treatment, adherence, as well as the dif-
ficulties and facilities found for correct conduction of the 
treatment until being cured. In addition to the interviews, a 
field diary was used with the aim of promoting hermeneutic 
reading. The testimonies were recorded and transcribed in 
full. The adapted and appropriate technique of discourse 
analysis based on the Theory of the Generation of Sense 
was used, which enables analyzing thematic phrases(10-11). 
Each subject received a letter of identification, followed by 
a number referring to the corresponding thematic phrase 
(example: B26 corresponds to the 26 thematic phrase of sub-
ject B). These thematic phrases were subsequently grouped 
and constituted the following sets of themes: the health-
disease process in MDR-TB and adherence to treatment.
The understanding that TB is socially determined was 
used for analysis of the study object. Such a conception places 
health and disease as moments of the same process, deter-
mined by the way each individual is inserted in the produc-
tion and social reproduction modes(12). Therefore, the health-
disease process is understood through the structural processes 
that govern society and which allow explaining the living 
conditions of the people and the social reproduction profiles 
of the different groups, from which the potentialities and/or 
attrition processes that influence health and disease occur(13). 
This project was approved by the Ethics Committee 
(process no. 996/2011) and all respondents participated by 
signing the clear and Informed Consent Form (ICF).
RESULTS
Twenty-one people were interviewed, 17 (80.9%) men 
and 4 (9.1%) women who adhered to the MDR-TB treat-
ment. The majority was in the age group between 18 and 
55 years (19; 90.4%), had 9 or more years of education (11; 
52.4%), lived with a partner (12; 57.1%) and had a fixed 
residence in the city of São Paulo (10, 47.5%). The charac-
teristics related to working and living conditions and to the 
health-disease process at the time of MDR-TB treatment 
are shown in Table 1. We can point out that 12 (57.2%) 
patients were unemployed or on sick leave, 18 (85.7%) stated 
that their income was sufficient for food, all were residing in 
brick housing, with apparently adequate housing conditions. 
It is very relevant that 3 (14.3%) people had previously had 
the treatment three times and that almost one third was 
alcohol and tobacco users.
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Table 1 – Distribution of study subjects according to characteristics 
related to working conditions, life conditions and health-disease 
process during the treatment of multidrug-resistant tuberculosis – 
São Paulo, SP, Brazil, 2012.
Characteristics of working conditions N %
Work status:
Employed 9 42.8
On sick leave 6 28.6
Unemployed 6 28.6
Characteristics of living conditions N %








Four or more rooms 14 66.7
Adequate ventilation and lighting 15 71.4
Characteristics of the health-disease process N %







Alcohol and tobacco 6 28.6
Analysis of the testimonies showed that adherence to 
MDR-TB treatment is a huge struggle (E41; G18; M12, 149), 
where you need to be really strong (B26, M72, 87, 121, 169). 
On this theme, three categories emerged: the desire to live, 
support for the development of treatment and the organiza-
tion of health services (Figure 1). Each analytical category 
is supported by constitutive elements, as shown in Chart 1.
The health-disease in
MDR-TB treatment













Figure 1 – Adherence to the treatment of multidrug-resistant 
tuberculosis.
Chart 1 – Categories of analysis and their constituent elements – 





Assistance from  
the health services
 – Treatment 
and life





 – Directly Observed Therapy
 – Medical consultations in the 
reference center
 – Free health care
Desire to live
According to the subjects, the desire to live is essential 
for adherence to treatment, because it allows to face the 
obstacles imposed by the disease. The testimonies pointed 
out that MDR-TB treatment is associated with life and that 
achieving health is considered as the first need and human 
value. The desire to fight against the disease is allied to the 
concern with the family, since the people affected by the 
illness feel like they are the providers and are responsible 
for maintaining the household.
MDR-TB is related to death, which paradoxically has 
repercussions on the desire to live and induces patients to 
adhere to treatment. The disease is considered by the inter-
viewees as severe (M175), for presenting more severe and 
intense signs and symptoms than the non-resistant form of 
pulmonary TB. Some signs and symptoms and conditions, 
reported as more severe were: bloody sputum, becoming 
bedridden, inability to develop simple everyday activities 
(bathing and walking), and dyspnea, which are associated 
with the sensation of being basically dead (C23; E30; J18; 
L1, 16; S21, 24; R20; P49, 67). 
support for the Development of treatment
The debilitation caused by the disease is brought about by 
the generalized feeling of weakness, evidenced by mention 
of the incapacity for the most basic everyday life activities 
(bathing and eating), and by the dependence of other people 
for accomplishing household activities and the incapacity to 
take care of children. 
On the other hand, family support during treatment and 
medical consultations was pointed out as very important for 
adherence to treatment, mainly due to the physical weak-
ness of the subjects, which also limits their commute to the 
health service. In addition, preparation of the patient’s food 
was pointed out as fundamental, which ensured more regular 
and better meals. 
The testimonies showed that the strength ( J28) and words 
of comfort and affection (C28, 29, 44; D21, 35; E26, 28; F17, 
18; G21; H17, 26; J19, 28; L6; O38, 39, 50, 71, 75; P72, 73; 
Q24, 25; R29; T31-33; U28) offered by family and friends 
during the disease treatment related to emotional support. 
The feeling of being loved by family members, friends, and 
health professionals was mentioned as being relevant for 
adherence to treatment. The bond with the health profes-
sional was characterized by user embracement, care, listen-
ing, attention, clarification of doubts, being called by their 
name, among others. This form of care evidences the health 
professional’s desire to help the subject overcome the disease.
The disease excludes the person from the labor mar-
ket, which triggers serious socioeconomic problems. The 
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weaknesses caused by not earning their monthly income 
on the subject and his/her family makes the material/finan-
cial support (offered by the government, non-governmen-
tal institutions, health professionals and family members) 
essential for maintaining their life and adherence to treat-
ment. Regarding this support, among the aids offered by 
the Tuberculosis Control Program we can point out the 
importance of the transportation voucher for monthly atten-
dance to medical consultations. The basic food package (cesta 
básica) and the financial support offered by the Bolsa Família 
(Family Grant) Programme were identified as enhancers 
of adherence to treatment, but also contribute to feeding 
dependent children. 
assistance from the health services
The representations that emerged from the testimonies 
reveal that Directly Observed Therapy (DOT) is a strategy 
that supports adherence to MDR-TB treatment and enables 
detection and monitoring of adverse reactions to medication. 
The need to sign the DOT follow-up form is understood by 
the patient as a requirement for the health care continuity, 
so that the subject believes that this instrument guarantees 
care continuity in the health unit. 
On the other hand, the need to attend medical appoint-
ments at the referral center is not perceived as beneficial, 
given the weaknesses caused by the long commute from 
home, the physical weakness to move, the inadequate con-
ditions of public transportation, the long waiting times 
for care, among other reasons. However, the quality of the 
care provided by the doctors and nurses of the service was 
emphasized, which contributed to treatment follow-up.
The medication provision by the public service is 
also considered as fundamental for the correct treatment 
follow-up: 
The drugs are expensive (...), if we had to buy them, (...) I would 
have died because I cannot afford it (A26; E45).
On the other hand, irregularity in the medication supply 
was mentioned, which made it difficult to perform the correct 
treatment (B30), although this fact did not interfere in the 
evolution to being cured.
The following were reported among the main obstacles 
to adherence: injectable medication, high number of pills, 
the long treatment time, daily visits to the health unit for 
accomplishing the DOT, and the attendance to the monthly 
consultations at the reference center.
DISCUSSION
The present study identified that the desire to live, sup-
port for developing the treatment and aspects related to 
health care, and the TB Control Program are elements that 
measure adherence to MDR-TB treatment. The findings 
show that adherence to MDR-TB treatment involves aspects 
which go beyond the singular and volitional dimension of 
the individual and refer to the way the Control Program 
operates, as well as the organization of health services. 
The interviewed subjects showed that treatment adher-
ence is strongly linked to the desire to be cured in the face of 
the inevitability of death. In addition to the life project, the 
personal motivation for treatment also stems from improve-
ment in the symptomatology, which gives greater hope of 
being cured and to overcoming barriers, corroborating other 
studies on this theme(9,14).
Physical and mental suffering was evidenced as a con-
sequence of the disease, which negatively affects the lives of 
patients who need to leave work and causes financial difficul-
ties, which has also been identified in other studies(15-16). In 
addition, the importance of family support is highlighted, 
especially when there is a shared home, which makes the 
health-disease process more humanized(16-18).
As this is a disease that is consecrated to social condi-
tions, there is a need for government protection through 
social protection policies, so that affected people can mini-
mize economic barriers imposed by illness and not aban-
don treatment. Regarding these measures, studies show that 
measures that alleviate suffering and financial burden such 
as social incentives, especially support for food and trans-
portation, can positively contribute to patients’ adherence to 
MDR-TB treatment, mainly due to the debilitating nature 
of the disease, the long-term care and loss of income, which 
may put these patients at special risk due to catastrophic 
costs(19-21). Despite these incentives such as the provision of 
basic food packages and transportation vouchers, these are 
palliative measures that are not capable of changing people’s 
living conditions, although they do contribute to coping 
with the disease(22). 
The means by which health care is organized in care ser-
vices and patient care consisted of an important result that 
emerged from the patients’ testimonials. In the study munici-
pality, MDR-TB treatment is performed through “coopera-
tive supervision” between the reference center and the health 
unit. This form of treatment being decentralized to better 
follow the patient’s treatment has also been observed in other 
countries, such as in South Africa and Peru, which perform 
the care in clinics close to patients’ homes or through home 
visits rather than hospitalizing them throughout the treat-
ment; a common practice in these countries and which has 
not been totally abolished in South Africa. These countries 
follow the Guidelines for Programmatic Management of 
Drug Resistant Tuberculosis formulated by WHO, which 
propose health education actions for the patient and family 
members, in addition to treatment(23-24).
The DOT is recommended by the Ministry of Health in 
Brazil, as well as by the WHO. It is not new that this treat-
ment modality assists in treatment adherence and curing 
the disease. However, DOT becomes even more important 
for MDR-TB treatment due to the frequent adverse reac-
tions and the long treatment period, which are the main 
reasons for treatment being discontinued(25). In addition, 
establishing a bond and trust, both of which are important 
for treatment adherence, are derived from daily contact, user 
embracement, and from qualified listening, which allows the 
professional to identify the needs of the person being treated 
for MDR-TB, in addition to sharing problems that afflict 
the patient, thereby enabling to strengthen the patient for 
the treatment(7,26).
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This study evidenced the shortcomings encountered by 
individuals with MDR-TB and who, even in adverse situa-
tions, were transposed, which resulted in them being cured. 
In addition, it has contributed to fill some knowledge gaps, 
as there is a lack of evidence on the obstacles faced by people 
with MDR-TB and on overcoming them(16).
CONCLUSION 
The present investigation indicates several issues involved 
in adherence to MDR-TB treatment. Above all, the rep-
resentations about the health-disease process focus on the 
desire to live, support for developing the treatment in all its 
dimensions (physical, emotional/psychological and financial) 
and how health services should offer the care and be orga-
nized to conduct the disease treatment. Although following 
the treatment in the health unit is a painful process, the 
DOT enables forming a bond and confidence to overcome 
the disease. In addition, the importance of the treatment 
being free was verified given the peculiar social insertion of 
the people affected by the illness. 
This study has also shown that there is a need to establish 
policies that improve living and working conditions which 
are a collective necessity, and as such should be the respon-
sibility of the State.
RESUMO
Objetivo: Identificar representações a respeito da adesão ao tratamento da tuberculose multidroga resistente na perspectiva de pacientes 
que obtiveram alta por cura. Método: Estudo qualitativo com pacientes que completaram o tratamento medicamentoso da tuberculose 
multidroga resistente em São Paulo. Utilizou-se da Determinação Social para interpretar o processo saúde-doença, e os depoimentos 
foram analisados segundo a hermenêutica-dialética e a técnica de análise de discurso. Resultados: Entrevistaram-se 21 pacientes. A 
maioria (80,9%) era homens, na faixa etária produtiva (90,4%) e afastada do trabalho ou desempregada (57,2%) durante o tratamento. 
Dos depoimentos, emergiram três categorias associadas à adesão ao tratamento: o desejo de viver, o suporte para o desenvolvimento do 
tratamento e a assistência nos serviços de saúde. Conclusão: Para a amostra do estudo, a adesão ao tratamento da tuberculose multidroga 
resistente esteve relacionada a ter um projeto de vida e ao apoio familiar e dos profissionais de saúde. A gratuidade do tratamento é 
fundamental para a adesão, dadas as fragilidades decorrentes da inserção social das pessoas acometidas pela doença. Requer-se, portanto, 
particular atenção dos serviços de saúde para compreender as necessidades dos doentes.  
DESCRITORES
Tuberculose; Tuberculose Resistente a Múltiplos Medicamentos; Adesão à Medicação; Acesso aos Serviços de Saúde; Enfermagem em 
Saúde Pública.
RESUMEN
Objetivo: Identificar representaciones respecto de la adhesión al tratamiento de la tuberculosis multidroga resistente en la perspectiva de 
pacientes que obtuvieron alta por curación. Método: Estudio cualitativo con pacientes que completaron el tratamiento medicamentoso 
de la tuberculosis multidroga resistente en São Paulo. Se utilizó la Determinación Social para interpretar el proceso salud-enfermedad, 
y las declaraciones fueron analizadas según la hermenéutica dialéctica y la técnica de análisis de discurso. Resultados: Se entrevistaron 
21 pacientes. La mayoría (80,9%) era hombres, en el rango de edad productiva (90,4%) y alejados del trabajo o desempleados (57,2%) 
durante el tratamiento. De las declaraciones emergieron tres categorías asociadas con la adhesión al tratamiento: el deseo de vivir, el 
soporte para el desarrollo del tratamiento y la asistencia en los servicios sanitarios. Conclusión: Para la muestra del estudio, la adhesión 
al tratamiento de la tuberculosis multidroga resistente estuvo relacionada con tener un proyecto de vida y con el apoyo familiar y 
los profesionales sanitarios. La gratuidad del tratamiento es fundamental para la adhesión, dadas las fragilidades consecuentes de la 
inserción social de las personas afectadas por la enfermedad. Se requiere, por lo tanto, particular atención de los servicios sanitarios a fin 
de comprender las necesidades de los enfermos. 
DESCRIPTORES
Tuberculosis; Tuberculosis Resistente a Múltiples Medicamentos; Cumplimiento de la Medicación; Accesibilidad a los Servicios de 
Salud; Enfermería de Salud Púbica.
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